Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs KIM✓SelectedUSD · KIMGSK vs KIM performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs KIM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
KIM return
+35.3%
Excess return
+11.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioKIMExcessAlpha
1D-0.1%+0.7%-0.8%-0.2%
7D-1.3%-0.2%-1.1%-1.3%
30D+2.7%+12.3%-9.6%+0.1%
3M+2.7%+6.7%-3.9%+1.2%
6M+3.3%+14.4%-11.1%+0.3%
YTD+6.5%+31.3%-24.8%+0.6%
1Y+10.7%+32.0%-21.4%+4.4%
3Y+64.4%+58.0%+6.3%+48.7%
5Y+46.7%+36.5%+10.1%+35.2%
All+46.7%+35.3%+11.4%+35.2%

Cumulative growth

Daily Returns

Daily percentage return beside KIM.

Daily Out/Under-Performance

Portfolio return minus KIM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × KIM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded KIM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling